Current methods for diagnosing skin cancer, such as dermoscopy, have limitations in sensitivity, leading to missed early-stage cancers and unnecessary biopsies of benign lesions. These diagnostic uncertainties can result in delayed treatment and increased patient morbidity.

DAMAE Medical's deepLive™ imaging system utilizes Line-field Confocal Optical Coherence Tomography (LC-OCT) to provide high-resolution, 3D imaging of skin lesions, offering a non-invasive alternative to traditional biopsy. The deepLive™ system allows clinicians to visualize skin structures at a cellular level, enabling more accurate differentiation between benign and malignant lesions. By providing detailed subsurface images, deepLive™ reduces the need for unnecessary biopsies and improves the early detection of skin cancers. The system's 3D imaging capabilities facilitate comprehensive assessment of skin conditions, promoting efficient and reassuring patient management.

Line-field Confocal Optical Coherence Tomography (LC-OCT) technology for high-resolution 3D imaging

Non-invasive imaging of skin lesions, reducing the need for biopsies

Vertical and horizontal imaging modes for comprehensive visualization

Quantitative skin analysis, including 3D segmentation of skin surface and dermo-epidermal junction

Analysis of keratinocyte distribution and density, as well as collagen fiber segmentation

Integration of live dermoscopic camera inside the LC-OCT 3D handheld probe

The primary users are dermatologists, oncologists, and other medical professionals involved in skin cancer diagnosis and treatment, as well as research institutions focused on dermatology and oncology.